SARTAX HCT 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

Active ingredient:

hydrochlorothiazide, Quantity: 12.5 mg; irbesartan, Quantity: 300 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Hydrochlorothiazide,Irbesartan

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000; iron oxide red; iron oxide yellow

Administration route:

Oral

Units in package:

30s

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.

Product summary:

Visual Identification: Peach coloured, oval shaped, biconvex, film coated tablet, debossed with "L184" on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2012-11-13